News
17h
New York Magazine on MSNA Prostate-Cancer Survivor Reacts to Joe Biden’s DiagnosisThere’s a lot we don’t know about the former president’s condition and probably didn’t need to know it earlier.
Joe Bidens cancer diagnosis has raised big questions about his health and future. At 82, the former president is battling ...
Prostate cancer is one of the most common types of cancer in men and grows very slowly, says NLM. Chances of a diagnosis ...
15h
ABC11 on MSNSurvivors share their prostate cancer stories, encourage men to get tested: 'Don't be afraid'David Johnson of Fayetteville tells ABC11 he has a lot to live for. That's why he says he's grateful his doctors caught his ...
Prostate cancer survivor Al Roker offered some words of support after former President Joe Biden publicly revealed he was ...
Former President Joe Biden is fighting a "aggressive" type of prostate cancer; his office said on Sunday that his illness is ...
Spatial transcriptomics may transform prostate cancer research by mapping immune cell localization and gene expression in ...
3d
News-Medical.Net on MSNGenomic study of non-Hispanic Black veterans with prostate cancer yields key insights for precision medicineIn the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer Center, University of Pennsylvania, University of ...
In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer ...
Quoc-Dien Trinh, MD, MBA, discusses a sub-analysis of the phase 3 ARANOTE trial, which focused on Black patients with metastatic hormone-sensitive prostate cancer.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results